RxDoctor Payments Data

John Prokop, DO

Family Medicine · Belpre, OHNPI 1396108676

Payments from drug & device makers

$752in general payments, 2019–2025

Across 45 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$161
  • Amarin Pharma, Inc.$76
  • Pfizer$75
  • Lilly USA, LLC$67
  • AstraZeneca$54
  • Amgen$52
  • plus $267 from 15 others

What the payments were for

  • Food & beverage$752100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$752 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$107,601
Medicare patients
533
Services billed
1,362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TakhzyroLanadelumab-Flyo11$668,141
EliquisApixaban199$198,131
JardianceEmpagliflozin79$119,327
OzempicSemaglutide68$81,726
TrulicityDulaglutide66$80,720
JanuviaSitagliptin Phosphate20$31,209
MounjaroTirzepatide26$26,799
LinzessLinaclotide25$22,383
ProliaDenosumab12$21,223
XareltoRivaroxaban26$19,369
FarxigaDapagliflozin Propanediol22$19,198
Spiriva HandihalerTiotropium Bromide20$16,993
Repatha SureclickEvolocumab26$14,365
MyrbetriqMirabegron13$12,016
Diclofenac Potassium12$9,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$75$198,131199 claims
Boehringer IngelheimJardiance$27$119,32779 claims
Lilly USA, LLCTrulicity, Mounjaro$67$107,51992 claims
AbbVieLinzess, Synthroid$161$27,882118 claims
AstraZenecaFarxiga, Symbicort$54$25,12741 claims
AmgenProlia$52$21,22312 claims
Johnson & JohnsonXarelto$15$19,36926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Belpre

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →